vs
Ceribell, Inc.（CBLL）与Streamex Corp.（STEX）财务数据对比。点击上方公司名可切换其他公司
Streamex Corp.净利率更高（155840.0% vs -54.6%，领先155894.6%）
Ceribell, Inc.是一家专注于神经诊断领域的医疗科技企业，主打便携式快速脑电图检测设备，可为急症、重症护理场景提供便捷的癫痫发作监测解决方案，核心市场覆盖北美地区，目前正逐步推进全球化业务布局。
CBLL vs STEX — 直观对比
营收规模更大
CBLL
是对方的-2478.4倍
$-10.0K
净利率更高
STEX
高出155894.6%
-54.6%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $24.8M | $-10.0K |
| 净利润 | $-13.5M | $-15.6M |
| 毛利率 | 87.3% | — |
| 营业利润率 | -58.9% | 61130.0% |
| 净利率 | -54.6% | 155840.0% |
| 营收同比 | — | — |
| 净利润同比 | — | -714.2% |
| 每股收益（稀释后） | $-0.35 | $-0.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CBLLSTEX
| Q4 25 | $24.8M | — | ||
| Q3 25 | $22.6M | $-10.0K | ||
| Q2 25 | $21.2M | $13.0K | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | — | $13.0K | ||
| Q3 24 | $17.2M | $0 | ||
| Q2 24 | — | $13.0K | ||
| Q1 24 | — | $14.0K |
净利润CBLLSTEX
| Q4 25 | $-13.5M | — | ||
| Q3 25 | $-13.5M | $-15.6M | ||
| Q2 25 | $-13.6M | $-20.4M | ||
| Q1 25 | $-12.8M | — | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-10.4M | $-1.9M | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | — | $-3.4M |
毛利率CBLLSTEX
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CBLLSTEX
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | 61130.0% | ||
| Q2 25 | -70.5% | -156653.8% | ||
| Q1 25 | -69.3% | — | ||
| Q4 24 | — | -9100.0% | ||
| Q3 24 | -57.8% | — | ||
| Q2 24 | — | -40707.7% | ||
| Q1 24 | — | -24550.0% |
净利率CBLLSTEX
| Q4 25 | -54.6% | — | ||
| Q3 25 | -59.6% | 155840.0% | ||
| Q2 25 | -64.4% | -156707.7% | ||
| Q1 25 | -62.4% | — | ||
| Q4 24 | — | -8453.8% | ||
| Q3 24 | -60.6% | — | ||
| Q2 24 | — | -30115.4% | ||
| Q1 24 | — | -24300.0% |
每股收益（稀释后）CBLLSTEX
| Q4 25 | $-0.35 | — | ||
| Q3 25 | $-0.37 | $-0.47 | ||
| Q2 25 | $-0.38 | $-0.74 | ||
| Q1 25 | $-0.36 | — | ||
| Q4 24 | — | $0.03 | ||
| Q3 24 | $-1.85 | $-0.12 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $155.3M | $-7.0M |
| 总资产 | $195.8M | $130.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CBLLSTEX
| Q4 25 | $159.3M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $177.4M | — | ||
| Q1 25 | $182.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $14.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CBLLSTEX
| Q4 25 | $155.3M | — | ||
| Q3 25 | $164.1M | $-7.0M | ||
| Q2 25 | $172.2M | $-3.6M | ||
| Q1 25 | $180.9M | — | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $-136.0M | $-405.0K | ||
| Q2 24 | — | $-6.0K | ||
| Q1 24 | — | $-4.3M |
总资产CBLLSTEX
| Q4 25 | $195.8M | — | ||
| Q3 25 | $199.5M | $130.5M | ||
| Q2 25 | $207.7M | $109.7M | ||
| Q1 25 | $213.5M | — | ||
| Q4 24 | — | $842.0K | ||
| Q3 24 | $47.1M | $1.4M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $1.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-10.8M | $-5.0M |
| 自由现金流经营现金流 - 资本支出 | $-11.0M | — |
| 自由现金流率自由现金流/营收 | -44.2% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.6M | — |
8季度趋势，按日历期对齐
经营现金流CBLLSTEX
| Q4 25 | $-10.8M | — | ||
| Q3 25 | $-11.1M | $-5.0M | ||
| Q2 25 | $-7.5M | $-1.3M | ||
| Q1 25 | $-11.4M | — | ||
| Q4 24 | — | $-474.0K | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | — | $-1.5M | ||
| Q1 24 | — | $-1.3M |
自由现金流CBLLSTEX
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CBLLSTEX
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CBLLSTEX
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
STEX
暂无分部数据
